scholarly journals Sex differences and the neurobiology of affective disorders

2018 ◽  
Vol 44 (1) ◽  
pp. 111-128 ◽  
Author(s):  
David R. Rubinow ◽  
Peter J. Schmidt
1993 ◽  
Vol 34 (3) ◽  
pp. 187-191 ◽  
Author(s):  
Richard C. Evenson ◽  
Scott T. Meier ◽  
Brian J. Hagan

2016 ◽  
Vol 18 (3) ◽  
pp. 272-281 ◽  
Author(s):  
Anne Høye ◽  
Ragnar Nesvåg ◽  
Ted Reichborn-Kjennerud ◽  
Bjarne K. Jacobsen

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Christopher Sikes-Keilp ◽  
David R. Rubinow

AbstractSex differences in the rates of affective disorders have been recognized for decades. Studies of physiologic sex-related differences in animals and humans, however, have generally yielded little in terms of explaining these differences. Furthermore, the significance of these findings is difficult to interpret given the dynamic, integrative, and highly context-dependent nature of human physiology. In this article, we provide an overview of the current literature on sex differences as they relate to mood disorders, organizing existing findings into five levels at which sex differences conceivably influence physiology relevant to affective states. These levels include the following: brain structure, network connectivity, signal transduction, transcription/translation, and epigenesis. We then evaluate the importance and limitations of this body of work, as well as offer perspectives on the future of research into sex differences. In creating this overview, we attempt to bring perspective to a body of research that is complex, poorly synthesized, and far from complete, as well as provide a theoretical framework for thinking about the role that sex differences ultimately play in affective regulation. Despite the overall gaps regarding both the underlying pathogenesis of affective illness and the role of sex-related factors in the development of affective disorders, it is evident that sex should be considered as an important contributor to alterations in neural function giving rise to susceptibility to and expression of depression.


Author(s):  
Maget A ◽  
Dalkner N ◽  
Hamm C ◽  
Bengesser SA ◽  
Fellendorf F ◽  
...  

2018 ◽  
Vol 20 (6) ◽  
Author(s):  
Liisa Hantsoo ◽  
Carla E. M. Golden ◽  
Sara Kornfield ◽  
Christian Grillon ◽  
C. Neill Epperson

2018 ◽  
Vol 30 (6) ◽  
pp. 323-333 ◽  
Author(s):  
Haim Einat ◽  
Itamar Ezer ◽  
Nirit Z Kara ◽  
Catherine Belzung

AbstractIntroductionLack of good animal models for affective disorders, including major depression and bipolar disorder, is noted as a major bottleneck in attempts to study these disorders and develop better treatments. We suggest that an important approach that can help in the development and use of better models is attention to variability between model animals.ResultsDifferences between mice strains were studied for some decades now, and sex differences get more attention than in the past. It is suggested that one factor that is mostly neglected, individual variability within groups, should get much more attention. The importance of individual differences in behavioral biology and ecology was repeatedly mentioned but its application to models of affective illness or to the study of drug response was not heavily studied. The standard approach is to overcome variability by standardization and by increasing the number of animals per group.ConclusionsPossibly, the individuality of specific animals and their unique responses to a variety of stimuli and drugs, can be helpful in deciphering the underlying biology of affective behaviors as well as offer better prediction of drug responses in patients.


1982 ◽  
Vol 51 (3_suppl) ◽  
pp. 1287-1306
Author(s):  
John B. Murray

Trends in research on affective disorders were reviewed. Studies which described the contribution of neurotransmitters and neuroendocrines to depression, unipolar and bipolar, and manic states were cited. Women more frequently suffer from affective disorders but women's response to different therapies sometimes is more favorable than men's. Age and married status influence sex differences in the incidence of affective disorders. Symptoms of pain and depression intertwine, and response to analgesia may emerge as an index of response to therapy for depression. Trends in pharmacotherapies for affective disorders were reviewed: lithium, tricyclic antidepressants, and MAOI drugs, as well as trends in the employment of ECT and sleep deprivation to relieve symptoms of affective disorders were reviewed.


Sign in / Sign up

Export Citation Format

Share Document